INV-25
N/A
Report date: 2022/07/11 15:23:25
NME
Base Information
Drug NameINV-25
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInnovimmune Biotherapeutics Holding LLC
China Registration ClassN/A
Develop Information
Active CompaniesInnovimmune Biotherapeutics Holding LLC
Inactive CompaniesN/A
Active Indications +[5]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A